JPMORGAN CHASE & CO - HALOZYME THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H959. A total of 4 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$590,000
+22.2%
35,000
+16.7%
0.00%–
Q1 2019$483,000
+10.0%
30,0000.0%0.00%–
Q4 2018$439,000
-78.3%
30,000
-70.0%
0.00%–
Q4 2017$2,026,000–100,000–0.00%–
 Download
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 10,100$385,7190.00%
SIMPLEX TRADING, LLC 4,500$1710.00%
JANE STREET GROUP, LLC 7,900$301,7010.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of HALOZYME THERAPEUTICS INC shareholders